eCARTv5 Clinical Deterioration Suite (eCART) vs DynaMed Decisions

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

DynaMed Decisions

by EBSCO Information Services

AI Verdict

While both eCARTv5 and DynaMed Decisions are clinical decision support tools, they serve distinct primary functions. eCARTv5 is an AI-powered, FDA-cleared solution focused on predicting clinical deterioration in hospitalized patients to guide early intervention. DynaMed Decisions, on the other hand, provides individualized clinical guidance, risk calculators, and patient decision aids to enhance overall clinical decision-making and patient engagement across a broader range of specialties.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your primary goal is to proactively identify and manage hospitalized adult patients at risk of clinical deterioration (death or ICU transfer). This AI-powered, FDA-cleared tool continuously assesses patient risk using real-time EHR data and provides early warnings, often hours before critical illness, guiding clinicians with embedded clinical pathways for timely intervention.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose DynaMed Decisions if…

Choose DynaMed Decisions if your focus is on enhancing individualized clinical decision-making, reducing provider burden, and driving meaningful patient engagement. This solution offers patient-specific guidance, risk calculators, and Option Grid patient decision aids to facilitate shared decision-making for preference-sensitive situations.

View DynaMed Decisions →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	DynaMed Decisions
Pricing	Contact vendor for tailored quote.	Contact for pricing
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Web-based, EHR integration (SMART on FHIR, HL7 Infobutton API, full API integration), mobile app access.
FDA Status	1 AI-estimated	Not applicable AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DynaMed Decisions

DynaMed Decisions offers web-based access, mobile app access, and multiple EHR integration methods (SMART on FHIR, HL7 Infobutton API, full API integration), suggesting broader accessibility and flexible deployment options. eCARTv5, while integrated with EHRs, focuses on a specific critical care workflow, potentially limiting its perceived general usability compared to DynaMed's broader approach including patient engagement tools.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) specifically designed for continuous, AI-powered prediction of clinical deterioration (death or ICU transfer), providing early warnings and embedded clinical pathways. This direct, high-impact clinical intervention for critical care situations offers a more defined and measurable clinical value in preventing adverse events compared to DynaMed Decisions' broader clinical guidance and decision support tools.

Pricing & Value

Tie

Both tools require direct contact for pricing, making a direct comparison of value difficult without specific quotes. While DynaMed has a related product (DynaMed) with publicly listed pricing, DynaMed Decisions itself requires separate licensing. Neither provides enough transparency to declare a winner on this dimension.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. eCARTv5 is an FDA-cleared SaMD with EHR integration and HIPAA compliance, indicating robust security and regulatory adherence. DynaMed Decisions also boasts EHR integration (SMART on FHIR, HL7, full API), HIPAA compliance, and a BAA, suggesting it is well-equipped for large-scale healthcare deployments. Without more specific details on scalability or existing enterprise client base, it's a tie.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 stands out for its FDA-cleared, AI-powered continuous prediction of clinical deterioration using up to 97 variables, providing early warnings hours before critical illness. This specific application of AI for proactive risk assessment and embedded clinical pathways represents a more novel and specialized innovation in critical care compared to DynaMed Decisions' more general individualized clinical guidance and patient decision aids.

Support & Docs

Tie

Neither product's provided information or readily available public data offers specific details about their support services, documentation quality, or training programs. Both are enterprise-level solutions, implying robust support, but without explicit information, it's impossible to differentiate them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	DynaMed Decisions
Name	eCARTv5 Clinical Deterioration Suite (u0093eCARTu0094)	DynaMed Decisions
Company	AgileMD	EBSCO Information Services
Tagline	AI-powered clinical decision support for better healthcare outcomes and efficiency.	An advanced clinical decision support solution providing individualized clinical guidance, risk calculators, and patient decision aids for personalized care.
Key Features	AI-powered clinical deterioration prediction; Continuous patient risk assessment (death or ICU transfer); EHR integration with real-time data (up to 97 variables); Embedded clinical pathways for care guidance; Early warning system (alerts hours before critical illness); Risk stratification (eCART score and risk designation); Minimizes false alarms and clinician workload; Reporting and benchmarking capabilities	Individualized clinical guidance; Risk calculators; Patient decision aids (Option Grid); Enhances clinical decision-making; Decreases burden on providers; Drives meaningful patient engagement; Interactive tools and evidence-based recommendations; Streamlines clinical workflows
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and DynaMed Decisions.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

eCARTv5 integrates directly into EHR systems, continuously assessing patients and guiding care with embedded clinical pathways. DynaMed Decisions offers deep EHR integration through SMART on FHIR, HL7 Infobutton API, and full API integration, aiming to streamline clinical workflows with interactive tools and recommendations.

What is the accuracy and sensitivity of each tool in identifying patient risks?

eCARTv5 uses an AI-powered gradient-boosted machine model that analyzes up to 97 real-time variables to predict clinical deterioration (death or ICU transfer) with high accuracy, demonstrating an AUROC of 0.834 in retrospective validation. DynaMed Decisions does not use AI and instead utilizes predictive models published in peer-reviewed literature, focusing on individualized clinical guidance and risk calculators.

Which specialties are these tools best suited for, and how do they cater to specific clinical contexts?

eCARTv5 is designed for critical care, emergency medicine, and hospital medicine, providing early warning for clinical deterioration in hospitalized adult patients across various medical conditions. DynaMed Decisions is suitable for family medicine, hospital medicine, and internal medicine, offering individualized guidance, risk calculators, and patient decision aids for a broad range of clinical scenarios and over 30 specialties.

What kind of learning curve can physicians expect with each tool, and what support is available?

While specific details on the learning curve are not provided, eCARTv5's integration with embedded clinical pathways suggests a guided workflow. DynaMed Decisions aims to decrease the burden on providers and streamline workflows with interactive tools and evidence-based recommendations, implying a focus on ease of use.

Are there audit-trail features available to track how the tools' recommendations are used and impact patient care?

The provided information does not explicitly detail audit-trail features for either eCARTv5 or DynaMed Decisions. However, as clinical decision support tools, the ability to track usage and impact is generally a key consideration for healthcare institutions.

How do these tools support multi-site rollouts and ensure consistent performance across different hospital environments?

eCARTv5 has been validated through extensive clinical performance data from nearly two million hospitalizations across 21 hospitals, ensuring consistent accuracy across diverse patient demographics and medical conditions, which suggests suitability for multi-site rollouts. DynaMed Decisions is a web-based solution with various EHR integration options, which would facilitate deployment across multiple sites, though specific multi-site performance consistency details are not provided.